Article Figures & Tables
Figures
Figure 1: Crude annual prevalence of antidepressant prescriptions per 1000 children (5–11 years), adolescents (12–17 years) and young adults (19–24 years) in the province of Manitoba, by fiscal year, before and after Health Canada issued a warning about antidepressant use in children and adolescents (date indicated by red line). People aged 18 years were excluded because of an unclear impact of the warning on prescribing in this age group. The dates are indicated for similar warnings issued in the United Kingdom (dashed line) and the United States (dotted line).
Figure 2: Crude annual prevalence of fluoxetine prescriptions per 1000 children (5–11 years), adolescents (12–17 years) and young adults (19–24 years) in the province of Manitoba, by fiscal year, before and after Health Canada issued a warning about antidepressant use in children and adolescents (date indicated by red line). People aged 18 years were excluded because of an unclear impact of the warning on prescribing in this age group. The dates are indicated for similar warnings issued in the United Kingdom (dashed line) and the United States (dotted line).
Figure 3: Crude annual rates of completed suicide per 1000 children and adolescents (8–17 years) and young adults (19–24 years), by year, before and after Health Canada issued a warning about antidepressant use in children and adolescents (date indicated by red line). People aged 18 years were excluded because of an unclear impact of the warning on prescribing in this age group. Data for years with fewer than 6 suicides, although included in the outcome analysis, are not portrayed in the figure for confidentiality purposes. The dates are indicated for similar warnings issued in the United Kingdom (dashed line) and the United States (dotted line).